Dysferlin in membrane trafficking and patch repair

被引:129
作者
Glover, Louise [1 ]
Brown, Robert H., Jr. [1 ]
机构
[1] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Day Neuromuscular Res Lab, Charlestown, MA 02129 USA
关键词
C2; domain; Ca2+-regulated exocytosis; membrane fusion; membrane repair; muscular dystrophy;
D O I
10.1111/j.1600-0854.2007.00573.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The muscular dystrophies are a heterogeneous group of inherited disorders, defined by progressive muscle weakness and atrophy. Following the discovery of dystrophin, remarkable progress has been made in defining the molecular properties of proteins involved in the various dystrophies. This has underlined the importance of the dystrophin-associated protein complex as a cell membrane scaffold, providing structural stability to muscle cells (McNeil PL, Khakee R. Disruptions of muscle fiber plasma membranes. Role in exercise-induced damage. Am J Pathol 1992;140:1097-1109). While the dystrophies linked to loss of function of dystrophin and its associated proteins are caused by diminished membrane integrity, it is now believed that a new class of dystrophies arises because of a diminished capacity for rapid muscle membrane repair after injury. Dysferlin is the first identified member of a putative muscle-specific repair complex that permits rapid resealing of membranes disrupted by mechanical stress. Membrane resealing is a function conserved by most cells and is mediated by a mechanism closely resembling regulated, Ca2+-dependent exocytosis. A primary role for dysferlin in this pathway, as a Ca2+-regulated fusogen, has been suggested, and a number of candidate partner proteins have been identified. This review outlines the current understanding of the role of dysferlin in membrane repair and the evolving picture of dysferlin-related signaling pathways in muscle cell physiology and pathology.
引用
收藏
页码:785 / 794
页数:10
相关论文
共 80 条
  • [1] Achanzar WE, 1997, J CELL SCI, V110, P1073
  • [2] Ampong Beryl N, 2005, Acta Myol, V24, P134
  • [3] Secondary reduction in calpain 3 expression in patients with limb girdle muscular dystrophy type 2B and Miyoshi myopathy (primary dysferlinopathies)
    Anderson, LVB
    Harrison, RM
    Pogue, R
    Vafiadaki, E
    Pollitt, C
    Davison, K
    Moss, JA
    Keers, S
    Pyle, A
    Shaw, PJ
    Mahjneh, I
    Argov, Z
    Greenberg, CR
    Wrogemann, K
    Bertorini, T
    Goebel, HH
    Beckmann, JS
    Bashir, R
    Bushby, KMD
    [J]. NEUROMUSCULAR DISORDERS, 2000, 10 (08) : 553 - 559
  • [4] Dysferlin is a plasma membrane protein and is expressed early in human development
    Anderson, LVB
    Davison, K
    Moss, JA
    Young, C
    Cullen, MJ
    Walsh, J
    Johnson, MA
    Bashir, R
    Britton, S
    Keers, S
    Argov, Z
    Mahjneh, I
    Fougerousse, F
    Beckmann, JS
    Bushby, KMD
    [J]. HUMAN MOLECULAR GENETICS, 1999, 8 (05) : 855 - 861
  • [5] ANDO Y, 1989, J BIOL CHEM, V264, P6948
  • [6] How does calcium trigger neurotransmitter release?
    Augustine, GJ
    [J]. CURRENT OPINION IN NEUROBIOLOGY, 2001, 11 (03) : 320 - 326
  • [7] The C2 domains of synaptotagmin - partners in exocytosis
    Bai, JH
    Chapman, ER
    [J]. TRENDS IN BIOCHEMICAL SCIENCES, 2004, 29 (03) : 143 - 151
  • [8] Defective membrane repair in dysferlin-deficient muscular dystrophy
    Bansal, D
    Miyake, K
    Vogel, SS
    Groh, S
    Chen, CC
    Williamson, R
    McNeil, PL
    Campbell, KP
    [J]. NATURE, 2003, 423 (6936) : 168 - 172
  • [9] Proteolytic signals in the primary structure of annexins
    Barnes, JA
    Gomes, AV
    [J]. MOLECULAR AND CELLULAR BIOCHEMISTRY, 2002, 231 (1-2) : 1 - 7
  • [10] AHNAK interaction with the annexin 2/S100A10 complex regulates cell membrane cytoarchitecture
    Benaud, C
    Gentil, BJ
    Assard, N
    Court, M
    Garin, J
    Delphin, C
    Baudier, J
    [J]. JOURNAL OF CELL BIOLOGY, 2004, 164 (01) : 133 - 144